4D pharma plc is a drug developer of live biotherapeutic products (LBPs), using individual bacteria strains to target certain diseases. The microbiome is a growing and exciting field of drug development and medicine, and 4D pharma is wellpositioned as an early adopter to become a market leader with its diverse portfolio of potentially disruptive LBPs. We believe there are multiple opportunities for value creation and potential upside, and that pending proof-of-concept data and business develo
14 Aug 2019
An early-adopter in the growing microbiome field
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
An early-adopter in the growing microbiome field
- Published:
14 Aug 2019 -
Author:
Edward Thomason -
Pages:
3
4D pharma plc is a drug developer of live biotherapeutic products (LBPs), using individual bacteria strains to target certain diseases. The microbiome is a growing and exciting field of drug development and medicine, and 4D pharma is wellpositioned as an early adopter to become a market leader with its diverse portfolio of potentially disruptive LBPs. We believe there are multiple opportunities for value creation and potential upside, and that pending proof-of-concept data and business develo